Filing Flows › DataMeds AI (MEDS) › Q3 2025
DataMeds AI (MEDS) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 19, 2025
DataMeds AI (MEDS) reported revenue of $3.0M for the third quarter 2025 (Q3 2025), -47% from a year earlier and -61% from the quarter before.
DataMeds AI, Q3 2025: revenue $3.0M (-47% year over year), net loss $34.3M, operating cash flow −$1.1M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.0M | -61% | -47% |
| Operating profit | −$31.5M | — | — |
| Net earnings | −$34.3M | — | — |
| Operating cash flow | −$1.1M | — | — |
What changed
Revenue was $3.0M in Q3 2025, down 47% year over year and down 61% from the previous quarter. Product was the largest line at 88% of revenue. Product lost $2.8M year over year (down 52%), 107% of the total change.
Gross margin was 7.7%, down 1.5 points from a year earlier. Operating costs exceeded revenue by $31.5M, an operating margin of -1047.1%. Operating expenses grew 1302% against a revenue fall of 47%. The fastest-growing cost line was General & admin (+1578%). The quarter ended with a net loss of $34.3M, wider than the previous quarter's $6.7M loss.
Operating cash flow was −$1.1M. Non-cash charges added back $803K of depreciation and amortization and $25.7M of share-based compensation. Working capital and other items added $6.6M.
Questions
What was DataMeds AI's revenue in the third quarter 2025?
DataMeds AI (MEDS) reported revenue of $3.0M for the third quarter 2025 (Q3 2025), -47% from a year earlier and -61% from the quarter before.
Source: DataMeds AI 10-Q on SEC EDGAR.